Actively Recruiting
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
Led by Kaohsiung Medical University Chung-Ho Memorial Hospital · Updated on 2022-04-08
150000
Participants Needed
1
Research Sites
1043 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan
CONDITIONS
Official Title
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who are treated with DAA and have willingness to participate in this registry.
You will not qualify if you...
- Chronic hepatitis C patients who are unwilling to participate in the study and do not provide written informed consent for participation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Kaohsiung City, Taiwan, 807
Actively Recruiting
Research Team
M
Ming-Lung Yu, MD., PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here